1. 1275PSafety and clinical activity of subcutaneously (SC) administered anti-PD-1 antibody PF-06801591 in phase I dose-expansion cohorts of locally advanced or metastatic non-small cell lung cancer (NSCLC) and urothelial carcinoma (UC). (1st October 2019) Authors: Cho, B C; Penkov, K; Bondarenko, I; Korozan, M; Kurochkin, A; Pikiel, J; Kulyaba, Y; Ahn, H K; Odintsova, S; Davda, J; Forgie, A; Wang, X; Li, R; Jacobs, I A; Kazazi, F; Chou, J; Johnson, M L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Appendicitis risk prediction models in children presenting with right iliac fossa pain (RIFT study): a prospective, multicentre validation study. (April 2020) Authors: Nepogodiev, Dmitri; Wilkin, Richard JW; Bradshaw, Catherine J; Skerritt, Clare; Ball, Alasdair; Moni-Nwinia, Waaka; Blanco-Colino, Ruth; Chauhan, Priyesh; Drake, Thomas M; Frasson, Matteo; Gee, Oliver; Glasbey, James C; Matthews, Jacob H; Morley, Gabriella L; Naumann, David N; Pata, Francesco; So... Journal: Lancet Issue: Volume 4:Number 4(2020) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗